Skip to main content

U.S. flag An official website of the United States government

Animal and Plant Health Inspection Service
U.S. Department of Agriculture
USDA FAQ's and resources about coronavirus (COVID-19).  LEARN MORE

Investigations

Investigation of alleged violations of the Virus-Serum-Toxin Act (VSTA) involving veterinary biologics can be divided into three categories:

  1. Violation of the VSTA by unlicensed manufacturer.
    This is the preparation, sale, barter, exchange or shipment of products by a manufacturer not licensed; the importation into the United States of an unlicensed product intended for the treatment, prevention, or diagnosis of disease in domestic animals; or the adulteration of licensed product by an unlicensed person.

  2. Violation of the VSTA by licensed manufacturer.
    This includes illegal movement of a known defective, licensed product or of an unlicensed product produced by a licensed manufacturer; importation into the United States by a licensed manufacturer of an unlicensed product intended for the treatment, prevention, or diagnosis of disease in domestic animals; or a licensed manufacturer making false or misleading claims about a licensed product.

  3. Violation of Regulations under the VSTA by licensed manufacturer.
    This occurs when conditions found upon inspection of a licensed manufacturer are not in accordance with 9 CFR, Parts 101 through 118. Action may also be taken under 9 CFR, Part 123.

Based on authority granted in the VSTA and regulations, CVB-IC takes appropriate action based on findings from product monitoring, inspection, or investigations. Recommendations for other actions are submitted to the Director, CVB.

Complementary Content
${loading}